Charles Freeman Geschickter
Charles Freeman Geschickter (1901–1987) was a prominent American pathologist and cancer researcher. He made significant contributions to the understanding of breast cancer and bone tumors. Geschickter's work in the field of oncology has had a lasting impact on medical research and cancer treatment.
Early Life and Education[edit | edit source]
Charles Freeman Geschickter was born in 1901. He pursued his medical education at the Johns Hopkins University School of Medicine, where he developed an interest in pathology and oncology. After completing his medical degree, he continued his training in pathology, focusing on the study of cancer.
Career[edit | edit source]
Geschickter began his career as a pathologist and researcher at Georgetown University Medical Center. He was known for his meticulous research and dedication to understanding the mechanisms of cancer development. His work primarily focused on breast cancer and bone tumors, areas in which he made groundbreaking discoveries.
Breast Cancer Research[edit | edit source]
One of Geschickter's most notable contributions was his research on breast cancer. He conducted extensive studies on the pathology of breast cancer, helping to identify various subtypes and their respective prognoses. His work laid the foundation for modern breast cancer diagnosis and treatment.
Bone Tumor Research[edit | edit source]
In addition to his work on breast cancer, Geschickter also made significant contributions to the study of bone tumors. He was instrumental in classifying different types of bone tumors and understanding their behavior. His research provided valuable insights into the diagnosis and treatment of these tumors.
Legacy[edit | edit source]
Charles Freeman Geschickter's contributions to the field of oncology have had a lasting impact on medical research and cancer treatment. His work has been widely cited and continues to influence contemporary cancer research. Geschickter's dedication to understanding cancer has helped pave the way for advancements in cancer diagnosis and therapy.
See Also[edit | edit source]
- Pathology
- Oncology
- Breast cancer
- Bone tumors
- Georgetown University Medical Center
- Johns Hopkins University School of Medicine
References[edit | edit source]
External Links[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD